People | University of Wisconsin Department of Ophthalmology and Visual Sciences

Ronald Danis, M.D.
Professor (CHS)

400 Science Drive
Madison, Wisconsin 53711
(608) 263-4538

rdanis@rc.ophth.wisc.edu

Education

Medical Degree: Northwestern University - 1983. Internship: Waterbury Hospital Health Center , Waterbury , CT. Residency: University of Wisconsin Hospital & Clinics, Madison. Fellowship: Research Pathology, University of Wisconsin Hospital & Clinics, Madison.
Retina Fellowship: Yale Eye Center , New Haven , CT. Specialty: Vitreoretinal disease, macular degeneration, diabetic retinopathy, retinal vascular disease, posterior ocular inflammatory disorder.

Research Summary

Dr. Danis is the Director of the UW Fundus Photograph Reading Center. This core facility serves more than 50 multicenter clinical trials and epidemiologic studies of retina diseases. Dr. Danis oversees the team of faculty and staff who together interpret the photographs, angiograms, and other images of the eye, and analyze the data for these studies. His research interests include new treatments for age-related macular degeneration, diabetic retinopathy, and other retinal diseases. He also investigates new methods for the detection of retinal disorders through imaging technology.

Representative Publications

May D, Kuhn F, Morris RE, Witherspoon CD, Danis RP, Matthews GP, Mann L. The epidemiology of serious eye injuries from the United States Eye Injury Registry. Graefe’s Arch Clin Exp Ophthalmol. 2000; 238(2):153-7.

Danis RP, Ciulla TA, Pratt LM, Anliker W. Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina 2000; 20: 244-250.

Yang Y, Danis RP, Peterson RG, Dolan PL, Wu Y. Acarbose partially inhibits microvascular retinopathy in the Zucker diabetic fatty rat (ZDF Gmi™-fa). J Ocul Pharmacol Ther. 2000; 16(5):471-479.

Danis, RP. Editorial: The birth of global ocular traumatology. Ophthalmic Epidemiol 2000; 7(2):85-86. (Unfunded research; Editorial)

Piper H, Ciulla TA, Danis RP, Pratt LM. Changing therapeutic paradigms in CMV retinitis and AIDS. Exp Opin Pharmacother 2000; 1(7):1343-52.

Woodburn R, Danis RP, Timmerman R, et al. Preliminary results of gamma knife radiosurgery in the treatment of choroidal melanoma. J Neurosurg 2000;(3)93:177-179.

Danis RP, Hu K, Bell M. Baseball face guards reduce oculofacial injury and are acceptable in receptive youth league baseball players. Inj Prev 2000:232-234.

Danis RP, Steffens T. Phototoxicity from systemic sodium fluorescein. Retina 20(4):370-373, 2000.

Danis RP. The birth of global ocular traumatology (editorial). Ophthalmic Epidemiology 7(2)85-86, 2000.

Henry SP, Danis RP. Potential therapeutic application of antisense oligonucleotides in the treatment of ocular diseases (review). Expert Opinion Pharmacotherapy 2001; 2(2):277-291.

Danis RP, Ciulla TA, Criswell M, Pratt L. Anti-angiogenic therapy of proliferative diabetic retinopathy (review). 2001; 2(3):395-407. Expert Opin Pharmacother

Ciulla TA, Curran-Celestano J, Cooper DA, Hammond BR, Danis RP, et al. Macular pigment optical density in a midwestern sample. Ophthalmology 2001; 108:730-737.

Ciulla TA, Criswell MH, Danis RP, Hill TE. Intravitreal triamcinolone acetonide inhibits choroidal neovascularization in a laser-treated rat model. Arch Ophthalmol 2001; 119:399-404.

Curran-Celestano J, Hammond BR, Ciulla TA, Cooper DA, Pratt, LM, Danis RP. Relation between dietary intake, serum concentrations, and retinal concentrations of lutein and zeaxanthin in adults in a Midwest population. Am J Clin Nutr 2001;74:796-802.

Ciulla TA, Harris A, Kagemann L, Danis RP, Pratt LM, Chung HS, Weinberger D,Garzozi HJ. Choroidal perfusion perturbations in non-neovascular age related macular degeneration. Br J Ophthalmol. 2002;86(2):209-13

Martidis A, Danis RP, Ciulla TA. Treating cytomegalovirus retinitis-related retinal detachment by combining silicone oil tamponade and ganciclovir implant. Ophthalmic Surg Lasers. 2002;33(2):135-9.

Ranson NT, Danis RP, Ciulla TA, Pratt L. Intravitreal triamcinolone in subfoveal recurrence of choroidal neovascularization after laser treatment in macular degeneration. Br J Ophthalmol. 2002;86(5):527-9.

Danis RP. Endophthalmitis. Ophthalmol Clin North Am 2002;15(2):243-8

Beyrau K, Danis RP. Outcomes of primary scleral buckling for stage 4 retinopathy of prematurity. Can J Ophthalmol. 2003:38(4):267-271.

Danis RP, Criswell MH, Orge F, Wancewicz EV, Stecker K, Henry SP, Monia BP. Intravitreous anti-raf-1 kinase antisense oligonucleotides as an angioinhibitory agent in porcine preretinal neovascularization. Curr Eye Res 2003:26(1):45-54.

Hudson J, Danis RP, Chaluvadi U, Allen S. Posttraumatic exogenous nocardia endophthalmitis due to trauma. Am J Ophthalmol. 2003;135(6 ):915-917.

Speicher MA, Danis RP, Criswell M, Pratt L. Pharmacologic therapy for diabetic retinopathy. Expert Opin Emerging Drugs. 2003:8(1):239-250.

Ciulla TA, Criswell MH, Danis RP, Williams JI, McLane MP, Holroyd KJ. Squalamine lactate reduces choroidal neovascularization in a laser-injury model in the rat. Retina. 2003;23(6):808-14.

Rechtman E, Danis RP, Allen V, Pratt LM. Treatment of choroidal neovascularization due to histoplasmosis by intravitreal triamcinolone. Am J Ophthalmol. 2003 Oct;136(4):739-41

Criswell MH, Ciulla TA, Hill TE, Small W, Danis RP, Snyder WJ, Lowseth LA, Carson DL. The squirrel monkey: characterization of a new-world primate model of experimental choroidal neovascularization and comparison with the macaque. Invest Ophthalmol Vis Sci. 2004;45(2):625-34.

Rechtman E, Danis RP, Pratt LM, Harris A. Intravitreal triamcinolone with photodynamic therapy for subfoveal choroidal neovascularization in age-related macular degeneration. Br J Ophthalmol 2004;88(3):344-7.

top